Pembrolizumab and Concurrent Chemoradiotherapy or Radiation Therapy in Treating Patients With Small Cell Lung Cancer

NCT02402920 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Extensive Stage Small Cell Lung Carcinoma
Limited Stage Small Cell Lung Carcinoma
Neuroendocrine Neoplasm

Interventions

DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Etoposide
OTHER: Laboratory Biomarker Analysis
BIOLOGICAL: Pembrolizumab
PROCEDURE: Radiation Therapy

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]